Telephone equal to in-person talk for BRCA1/2 genetic counseling

This article originally appeared here.
Telephone Delivery OK for <i>BRCA1/2</i> Genetic Counseling
Telephone Delivery OK for BRCA1/2 Genetic Counseling

(HealthDay News) -- The psychosocial outcomes of telephone genetic counseling are noninferior to standard in-person genetic counseling for BRCA1/2 gene testing, according to research published online Jan. 21 in the Journal of Clinical Oncology.

Marc D. Schwartz, Ph.D., of Georgetown University in Washington, D.C., and colleagues randomly assigned women, aged 21 to 85 years, who did not have newly diagnosed or metastatic cancer, to telephone counseling (335 participants) or usual care (334 participants). The authors sought to determine whether telephone counseling was noninferior to in-person counseling for BRCA1/2 gene testing.

The researchers found that, at two weeks after pretest counseling, telephone counseling was noninferior to usual care for all primary outcomes, including knowledge, perceived stress, satisfaction, decision conflict, and cancer distress. Telephone counseling was not equivalent to usual care for the uptake of BRCA1/2 testing. Per patient, telephone counseling cost $114 less per patient than usual care.

"It is time to embrace telephone genetic counseling as a legitimate and effective way to increase patient access to genetic counseling services," writes the author of an accompanying editorial.

Several authors disclosed financial ties to pharmaceutical and/or biomedical companies.

Abstract
Full Text (subscription or payment may be required)
Editorial

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs